@article{8f1a54beda95445f9dfd9da0cefc3e08,
title = "Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial.",
keywords = "EPIDERMAL STEM-CELLS, DOWLING-MEARA, GENE, MUTATIONS, AMPLIFICATION, DISORDERS, KERATIN-5, SAFETY, EBS",
author = "Verena Wally and Alain Hovnanian and Juliette Ly and Hana Buckova and Victoria Brunner and Thomas Lettner and Michael Ablinger and Thomas Felder and Peter Hofbauer and Martin Wolkersdorfer and Florian Lagler and Wolfgang Hitzl and Martin Laimer and Sophie Kitzm{\"u}ller and Anja Diem and Johann Bauer",
note = "Wally, Brunner, Lettner, Ablinger, Kitzm{\"u}ller, Diem: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Dept. of Dermatology, University Hospital Salzburg - Lagler: Institute for Inborn Errors of Metabolism and Department of Pediatrics - Hitzl: Research Office, Biostatistics - Felder: Dept. of Laboratory Medicine - Laimer, Bauer: Dept. of Dermatology, University Hospital Salzburg, all: Paracelsus Medical University Salzburg, Austria",
year = "2018",
doi = "10.1016/j.jaad.2018.01.019",
language = "English",
volume = "78",
pages = "892--901.e7",
journal = "JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY ",
issn = "0190-9622",
number = "5",
}